| Title |
Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis
|
|---|---|
| Published in |
PharmacoEconomics, December 2019
|
| DOI | 10.1007/s40273-019-00864-8 |
| Pubmed ID | |
| Authors |
T. Joseph Mattingly, Julia F. Slejko, Eberechukwu Onukwugha, Eleanor M. Perfetto, Shyamasundaran Kottilil, C. Daniel Mullins |
X Demographics
The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | 29% |
| New Zealand | 3 | 18% |
| Spain | 1 | 6% |
| Australia | 1 | 6% |
| United Kingdom | 1 | 6% |
| Unknown | 6 | 35% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 11 | 65% |
| Scientists | 4 | 24% |
| Science communicators (journalists, bloggers, editors) | 2 | 12% |
Mendeley readers
The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 48 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 9 | 19% |
| Student > Ph. D. Student | 4 | 8% |
| Student > Bachelor | 3 | 6% |
| Student > Doctoral Student | 2 | 4% |
| Student > Postgraduate | 2 | 4% |
| Other | 4 | 8% |
| Unknown | 24 | 50% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 8 | 17% |
| Biochemistry, Genetics and Molecular Biology | 3 | 6% |
| Economics, Econometrics and Finance | 3 | 6% |
| Business, Management and Accounting | 2 | 4% |
| Social Sciences | 2 | 4% |
| Other | 6 | 13% |
| Unknown | 24 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 October 2023.
All research outputs
#1,573,047
of 25,870,142 outputs
Outputs from PharmacoEconomics
#75
of 2,004 outputs
Outputs of similar age
#37,205
of 479,999 outputs
Outputs of similar age from PharmacoEconomics
#5
of 34 outputs
Altmetric has tracked 25,870,142 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,004 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 479,999 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.